What's new

Human medicines European public assessment report (EPAR): Camcevi, leuprorelin, Date of authorisation: 24/05/2022, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR): Camcevi, leuprorelin, Date of authorisation: 24/05/2022, Revision: 5, Status: Authorised

Apr 3, 2025 - 14:53
 0
Human medicines European public assessment report (EPAR): Camcevi, leuprorelin, Date of authorisation: 24/05/2022, Revision: 5, Status: Authorised
Human medicines European public assessment report (EPAR): Camcevi, leuprorelin, Date of authorisation: 24/05/2022, Revision: 5, Status: Authorised
Read More

Tags:

Previous Article

Stellantis idles plants in Mexico and Canada due to tariffs

Next Article

Indian heavy industry offers 20GW solar PV opportunity

Related Posts

Human medicines European public assessment report (EPAR): Xalkori, crizotinib, Date of authorisation: 23/10/2012, Revision: 37, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 27, 2025  0

Human medicines European public assessment report (EPAR): Mirvaso, brimonidine, Date of authorisation: 20/02/2014, Revision: 14, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 4, 2025  0

Human medicines European public assessment report (EPAR): Efmody, hydrocortisone, Date of authorisation: 27/05/2021, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 31, 2025  0